Alpha-synuclein preformed fibrils: a tool to understand Parkinson's disease and develop disease modifying therapy

被引:5
|
作者
Chmielarz, Piotr [1 ,2 ]
Domanskyi, Andrii [1 ,3 ]
机构
[1] Univ Helsinki, Inst Biotechnol, HiLIFE, Helsinki, Finland
[2] Polish Acad Sci, Maj Inst Pharmacol, Dept Brain Biochem, Krakow, Poland
[3] Orion Corp Orion Pharma, Turku, Finland
基金
芬兰科学院;
关键词
PATHOLOGY;
D O I
10.4103/1673-5374.310686
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:2219 / 2221
页数:3
相关论文
共 50 条
  • [21] Modeling Parkinson's Disease With the Alpha-Synuclein Protein
    Gomez-Benito, Monica
    Granado, Noelia
    Garcia-Sanz, Patricia
    Michel, Anne
    Dumoulin, Mireille
    Moratalla, Rosario
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [22] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
  • [23] Lipids and alpha-synuclein aggregation in Parkinson's disease
    Broersen, K.
    Davletov, B.
    MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
  • [24] Familial Parkinson's disease - The awakening of alpha-synuclein
    Goedert, M
    NATURE, 1997, 388 (6639) : 232 - 233
  • [25] Sumoylation of alpha-synuclein in the pathogenesis of parkinson's disease
    Engelender, S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 48 - 48
  • [26] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
  • [27] A Characterization of Misfolded Alpha-Synuclein in Parkinson's Disease
    Shannon, Daniel
    Bugada, John-Paul
    Collins, Ethan
    Fischer, Ellie
    Hellard, Delaney
    Hoffman, Trevor
    Kellogg, Nick
    Peters, Kyle
    Poetker, Garret
    Young, Logan
    Diao, JiaJie
    FASEB JOURNAL, 2020, 34
  • [28] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
    Dolgacheva L.P.
    Fedotova E.I.
    Abramov A.Y.
    Berezhnov A.V.
    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2018, 12 (1) : 10 - 19
  • [29] Alpha-synuclein and presynaptic functionImplications for Parkinson’s disease
    Simon Lykkebo
    Poul Henning Jensen
    NeuroMolecular Medicine, 2002, 2 : 115 - 129
  • [30] Role of alpha-synuclein and tau in Parkinson's disease
    Trojanowski, JQ
    MOVEMENT DISORDERS, 2004, 19 : S2 - S2